IFOSFAMIDE
These highlights do not include all the information needed to use Ifosfamide for Injection safely and effectively. See full prescribing information for Ifosfamide for Injection.Ifosfamide for injection, intravenous useInitial U.S. Approval: 1988
Approved
Approval ID
91e433a9-6800-43a6-ac13-a49a04a5aecd
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 30, 2018
Manufacturers
FDA
Baxter Healthcare Corporation
DUNS: 005083209
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
IFOSFAMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-926
Application NumberNDA019763
Product Classification
M
Marketing Category
C73594
G
Generic Name
IFOSFAMIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 28, 2014
FDA Product Classification
INGREDIENTS (1)
IFOSFAMIDEActive
Quantity: 3 g in 60 mL
Code: UM20QQM95Y
Classification: ACTIB
IFOSFAMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10019-925
Application NumberNDA019763
Product Classification
M
Marketing Category
C73594
G
Generic Name
IFOSFAMIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 28, 2014
FDA Product Classification
INGREDIENTS (1)
IFOSFAMIDEActive
Quantity: 1 g in 20 mL
Code: UM20QQM95Y
Classification: ACTIB